← Leaderboards
Michael W Fried
University Of North Carolina Chapel Hill
$8,954,521
Attributed
$8,954,521
Total exposure
10
Grants
6
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $633.3K · FY2005–19$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
Funding mix
By agency
NIH$8,954,521 · 10
By mechanism
U01$5,485,230 · 3
R01$1,551,360 · 1
K24$1,481,784 · 1
M01$392,497 · 4
P60$43,650 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of North Carolina Chapel Hill
Same institution · by research overlap
- Kuo-Hsiung Lee$16,683,783
- Roy L Hawke$690,706
- William B Klimstra$13,808,129
- Gary M Pollack$1,883,076
- Carl Bose$7,998,029
Others in their field
Top investigators on “Clinical Trials”
- Lawrence Corey · Fred Hutchinson Cancer Center$824,102,536
- Sonia M Thomas · Research Triangle Institute$700,865,642
- David Heimbrook · Leidos Biomedical Research, Inc.$622,583,125
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$542,008,718
- Bambra Strokes · Ppd Development Lp$526,656,217
- Judith S. Currier · University Of California Los Angeles$504,273,077
Research focus
Clinical TrialsSerumLiver DiseasesComorbidityResponseClinical ResearchHepatitis C VirusEnrollmentHepatitis CNorth CarolinaViralAntiviral AgentsUniversitiesPathogenesisDesignHepatitis BAntiviral TherapyLiverPeripheral Blood Mononuclear CellProgramsChronic Hepatitis BCooperative StudyParticipantInflammation
Grant awards (45)
North Carolina Hepatitis B Research Network$283,861
U01 · FY2019 · DK · contact PI
North Carolina Hepatitis B Research Network$262,153
U01 · FY2018 · DK · contact PI
North Carolina Hepatitis B Research Network$308,115
U01 · FY2017 · DK · contact PI
North Carolina Hepatitis B Research Network$294,577
U01 · FY2016 · DK · contact PI
North Carolina Hepatitis B Research Network$63,560
U01 · FY2016 · DK · contact PI
North Carolina Hepatitis B Research Network$247,537
U01 · FY2015 · DK · contact PI
Mentoring Junior Faculty: Viral hepatitis Clinical Research$153,330
K24 · FY2014 · DK · contact PI
The North Carolina Hepatitis Beta Clinical Research Network$144,094
U01 · FY2014 · DK · contact PI
The North Carolina Hepatitis Beta Clinical Research Network$349,580
U01 · FY2013 · DK · contact PI
Mentoring Junior Faculty: Viral hepatitis Clinical Research$153,330
K24 · FY2013 · DK · contact PI
The North Carolina Hepatitis Beta Clinical Research Network$372,007
U01 · FY2012 · DK · contact PI
Mentoring Junior Faculty: Viral hepatitis Clinical Research$153,330
K24 · FY2012 · DK · contact PI
The North Carolina Hepatitis Beta Clinical Research Network$220,192
U01 · FY2011 · DK · contact PI
Mentoring Junior Faculty: Viral hepatitis Clinical Research$162,645
K24 · FY2011 · DK · contact PI
The North Carolina Hepatitis Beta Clinical Research Network$320,450
U01 · FY2010 · DK · contact PI
Mentoring Junior Faculty: Viral hepatitis Clinical Research$162,564
K24 · FY2010 · DK · contact PI
The North Carolina Hepatitis Beta Clinical Research Network$415,945
U01 · FY2009 · DK · contact PI
A phase I/II randomized, placebo controlled trial of silymarin for hepatitis C$344,624
U01 · FY2008 · AT · contact PI
The North Carolina Hepatitis Beta Clinical Research Network$149,081
U01 · FY2008 · DK · contact PI
Mentoring Junior Faculty: Hepatitis C Clinical Research$139,317
K24 · FY2008 · DK · contact PI
DIVISION OF DIGESTIVE DISEASES SERUM AND TISSUE BANK$230
M01 · FY2008 · RR · contact PI
A phase I/II randomized, placebo controlled trial of silymarin for hepatitis C$287,241
U01 · FY2007 · AT · contact PI
Mentoring Junior Faculty: Hepatitis C Clinical Research$139,317
K24 · FY2007 · DK · contact PI
A phase I/II randomized, placebo controlled trial of silymarin for hepatitis C$42,515
U01 · FY2007 · AT · contact PI
A phase I/II randomized, placebo controlled trial of silymarin for hepatitis C$149,358
U01 · FY2006 · AT · contact PI
Mentoring Junior Faculty: Hepatitis C Clinical Research$139,317
K24 · FY2006 · DK · contact PI
VIRAHEP-C: A STUDY OF ANTIVIRAL RESISTANCE IN AFR AMER/CAUCASIAN-HEP C$13,381
M01 · FY2006 · RR · contact PI
PEGASYS PLUS AMANTADINE AND PEGASYS PLUS AMANTADINE PLUS RIBAVIRIN$248
M01 · FY2006 · RR · contact PI
Mentoring Junior Faculty: Hepatitis C Clinical Research$139,317
K24 · FY2005 · DK
VIRAHEP-C: A STUDY OF ANTIVIRAL RESISTANCE IN AFR AMER/CAUCASIAN-HEP C$135,714
M01 · FY2005 · RR
Hepatitis C Antiviral Resistance in African Americans$105,000
U01 · FY2005 · DK
INTERFERON RESISTANCE IN AFRICAN-AMERICANS$942
M01 · FY2005 · RR
Virahep-C: A Study of Antiviral Resistance in Afr. Amer./Caucasian-Hep C$187,076
M01 · FY2004 · RR
Hepatitis C Antiviral Resistance in African Americans$175,000
U01 · FY2004 · DK
Mentoring Junior Faculty: Hepatitis C Clinical Research$139,317
K24 · FY2004 · DK
Interferon Resistance in African-Americans$54,906
M01 · FY2004 · RR
PILOT--ALCOHOL AND HEPATITIS C HOST RESPONSE AND DISEASE ACTIVITY$21,825
P60 · FY2004 · AA
Hepatitis C Antiviral Resistance in African Americans$350,000
U01 · FY2003 · DK
PILOT--ALCOHOL AND HEPATITIS C HOST RESPONSE AND DISEASE ACTIVITY$21,825
P60 · FY2003 · AA
HEPATITIS C IN CLINICALLY DISCORDANT HEMOPHILIC SIBLINGS$526,432
R01 · FY2002 · HL
Hepatitis C Antiviral Resistance in African Americans$375,000
U01 · FY2002 · DK
HEPATITIS C IN CLINICALLY DISCORDANT HEMOPHILIC SIBLINGS$516,718
R01 · FY2001 · HL
Hepatitis C Antiviral Resistance in African Americans$225,340
U01 · FY2001 · DK
HEPATITIS C IN CLINICALLY DISCORDANT HEMOPHILIC SIBLINGS$435,668
R01 · FY2000 · HL
HEPATITIS C IN CLINICALLY DISCORDANT HEMOPHILIC SIBLINGS$72,542
R01 · FY2000 · HL